Thompson Oncology Group-Maryville is a clinical research site located in Maryville, Tennessee, United States 37804.
Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.
Thompson Oncology Group-Maryville has participated in 2 clinical trials with 1 currently active.
Therapeutic areas: Metastatic Breast Adenocarcinoma, Metastatic HER2-Positive Breast Carcinoma, Recurrent Breast Adenocarcinoma.
Sponsors: National Cancer Institute (NCI), NRG Oncology.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Tennessee · View every site in Maryville
Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Thompson Oncology Group-Maryville has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Thompson Oncology Group-Maryville has 2 clinical trials on record, with 1 currently active. Their work covers Metastatic Breast Adenocarcinoma, Metastatic HER2-Positive Breast Carcinoma, Recurrent Breast Adenocarcinoma.
Thompson Oncology Group-Maryville has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.